| Authors: |
Mariscal A; Immunology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. Electronic address: amariscal@santpau.cat., Martínez C; AHEAD Therapeutics S.L. Barcelona, Spain., Goethals L; Sorbonne University, INSERM, Association Institute of Myology, Center of Research in Myology, UMRS 974, Paris, France., Cortés-Vicente E; Neuromuscular Diseases Unit, Neurology Department, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Neuromuscular Disorders Laboratory, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Moltó E; Immunology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Juárez C; Immunology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Barneda-Zahonero B; AHEAD Therapeutics S.L. Barcelona, Spain., Querol L; Neuromuscular Diseases Unit, Neurology Department, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Neuromuscular Disorders Laboratory, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Le Panse R; Sorbonne University, INSERM, Association Institute of Myology, Center of Research in Myology, UMRS 974, Paris, France., Gallardo E; Neuromuscular Disorders Laboratory, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. |